… Conflict-of-interest statement: Lodhia N has served as a consultant for Medtronic. No … Nilesh
Lodhia, Division of Gastroenterology and Hepatology, University of North Carolina, Charlotte…

Surgeons often care for patients with inflammatory bowel disease (IBD) who are receiving
therapies that can include 5-aminosalicylic acid (5-ASA) compounds, steroids, …

AIM: To evaluate the incidence of contrast-induced nephropathy (CIN) in cirrhotic patients
and to identify risk factors for the development of CIN. METHODS: We performed a …

Successful esophageal emptying depends on the generation of a sustained intrabolus pressure
(IBP) sufficient to overcome esophagogastric junction (EGJ) obstruction. Our aim was to …

Primary care physicians care for patients with inflammatory bowel disease (IBD) who are
receiving advanced therapies that include immunomodulator drugs (eg, azathioprine and …

BACKGROUND Esophageal bolus clearance requires a preferential esophagogastric
pressure gradient sustained for a sufficient period. We aimed to validate a high-resolution …

Biologics and immunomodulators (IMM) are generally considered the most effective therapies
for the treatment of ulcerative colitis and Crohn’s disease. However, despite the efficacy of …

AIM: To investigate, in the largest cohort to date, patient characteristics and associated risk
factors for developing small intestinal bacterial overgrowth (SIBO) using the D-Xylose breath …

An increasing majority of patients with inflammatory bowel disease (IBD) will be placed on
immunosuppressive medications, thus increasing their susceptibility to infections. Although …

Acute portal vein thrombosis (PVT) may occur in the presence or absence of underlying liver
disease and can be due to multiple causes. Because of the heterogeneity of both the extent …